These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16782375)

  • 21. Forced expiratory volume in 1 second percentage improves the classification of severity among children with asthma.
    Fuhlbrigge AL; Weiss ST; Kuntz KM; Paltiel AD;
    Pediatrics; 2006 Aug; 118(2):e347-55. PubMed ID: 16864642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between clinical classification, PEF and FEV1: guidelines and reality.
    Palma-Carlos AG; Palma-Carlos ML
    Allerg Immunol (Paris); 2002 Oct; 34(8):274-6. PubMed ID: 12449664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lung function at 10 yrs is not improved by early corticosteroid treatment in asthmatic children.
    Lødrup Carlsen KC; Devulapalli CS; Mowinckel P; Håland G; Munthe-Kaas MC; Carlsen KH
    Pediatr Allergy Immunol; 2010 Aug; 21(5):814-22. PubMed ID: 19912549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improvement of asthma therapy by a novel budesonide multidose dry powder inhaler.
    Möller M; Fritsche D; Rivera D; Libertus H
    Arzneimittelforschung; 2003; 53(8):562-7. PubMed ID: 13677246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peak expiratory flow-guided self-management treatment of asthma in Serbia.
    Milenković BA; Stanković IJ; Ilić AM; Petrović VI
    J Asthma; 2007 Nov; 44(9):699-704. PubMed ID: 17994397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma.
    Flood-Page P; Swenson C; Faiferman I; Matthews J; Williams M; Brannick L; Robinson D; Wenzel S; Busse W; Hansel TT; Barnes NC;
    Am J Respir Crit Care Med; 2007 Dec; 176(11):1062-71. PubMed ID: 17872493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compliance with guidelines in the treatment of asthma exacerbations in primary care.
    Flor-Escriche X; Rodríguez-Mas M; Espiau M; Castán-Enseñat X; Vigatà-Reig JM; Poblet-Cortés R; Miravitlles M
    Ther Adv Respir Dis; 2011 Dec; 5(6):369-75. PubMed ID: 21921074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Symptoms, FEV1/FVC, and peak flow as indices of the control of asthma].
    Zang M; Nishimura K; Ikeda A; Tsukino M; Koyama H; Izumi T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Mar; 34(3):270-4. PubMed ID: 8778465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
    Galant SP; van Bavel J; Finn A; Gross G; Pleskow W; Brown A; Hamedani AG; Harding SM
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of omalizumab in patients with inadequately controlled severe persistent allergic asthma: an open-label study.
    Niven R; Chung KF; Panahloo Z; Blogg M; Ayre G
    Respir Med; 2008 Oct; 102(10):1371-8. PubMed ID: 18657960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new perspective on concepts of asthma severity and control.
    Taylor DR; Bateman ED; Boulet LP; Boushey HA; Busse WW; Casale TB; Chanez P; Enright PL; Gibson PG; de Jongste JC; Kerstjens HA; Lazarus SC; Levy ML; O'Byrne PM; Partridge MR; Pavord ID; Sears MR; Sterk PJ; Stoloff SW; Szefler SJ; Sullivan SD; Thomas MD; Wenzel SE; Reddel HK
    Eur Respir J; 2008 Sep; 32(3):545-54. PubMed ID: 18757695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group.
    Sont JK; Willems LN; Bel EH; van Krieken JH; Vandenbroucke JP; Sterk PJ
    Am J Respir Crit Care Med; 1999 Apr; 159(4 Pt 1):1043-51. PubMed ID: 10194144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The misuse of asthma drugs.
    Colice GL
    Expert Rev Respir Med; 2013 Jun; 7(3):307-20. PubMed ID: 23734651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leukotriene antagonists in asthma.
    Lipworth B; Jackson C
    N Engl J Med; 2011 Jul; 365(3):272-3; author reply 273-4. PubMed ID: 21774722
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of acute asthma].
    Bavbek S
    Tuberk Toraks; 2005; 53(1):80-94. PubMed ID: 15765293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of spirometry and symptom scores in childhood asthma and the usefulness of curvature assessment in expiratory flow-volume curves.
    Wildhaber JH; Sznitman J; Harpes P; Straub D; Möller A; Basek P; Sennhauser FH
    Respir Care; 2007 Dec; 52(12):1744-52. PubMed ID: 18028566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of ciclesonide once daily and fluticasone propionate twice daily in children with asthma.
    Pedersen S; Engelstätter R; Weber HJ; Hirsch S; Barkai L; Emeryk A; Weber H; Vermeulen J
    Pulm Pharmacol Ther; 2009 Jun; 22(3):214-20. PubMed ID: 19141327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of treatment with montelukast on levels of serum interleukin-10, eosinophil cationic protein, blood eosinophil counts, and clinical parameters in children with asthma.
    Yüksel B; Aydemir C; Ustündag G; Eldeş N; Kutsal E; Can M; Demirtaş S; Tomaç N
    Turk J Pediatr; 2009; 51(5):460-5. PubMed ID: 20112601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Home telemonitoring (forced expiratory volume in 1 s) in children with severe asthma does not reduce exacerbations.
    Deschildre A; Béghin L; Salleron J; Iliescu C; Thumerelle C; Santos C; Hoorelbeke A; Scalbert M; Pouessel G; Gnansounou M; Edmé JL; Matran R
    Eur Respir J; 2012 Feb; 39(2):290-6. PubMed ID: 21852334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improvement of asthma therapy by a novel formoterol multidose dry powder inhaler.
    Moeller M; Grimmbacher S; Munzel U
    Arzneimittelforschung; 2008; 58(4):168-73. PubMed ID: 18540478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.